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ABSTRACT 
 
 
 
 This project was designed to generate a recombinant vaccinia virus expressing the new 
H5 subtype of the HA gene as part of eventually defining the CTL epitope on the avian HA 
protein recognized by this human T cell clone.   The result was achieved by first generating a 
transfer vector for homologous recombination. The vector was used to generate a recombinant 
vaccinia virus expressing the HA gene. Expression of the HA gene product was confirmed at 
both transcriptional and translational levels, using RT-PCR and immunoprecipitations, 
respectively.  
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BACKGROUND 
 
Human Influenza A Virus 
 
Influenza A virus infections cause morbidity and mortality on an annual basis (Langmuir 
and Schoenbaum, 1977; Stuart Harris and Schild, 1976). Excessive mortality is usually observed 
in the elderly and in individuals with chronic illness. Although older children and adults 
generally have had previous infections with influenza A viruses, mutations at the major antibody 
(Ab) combining sites allow reinfections to occur (Webster et al., 1992). These point mutations 
cause antigenic drift at the Ab combining sites on the external glycoproteins, hemagglutinin 
(HA) and neuraminidase (NA). In addition, periodically a drastic Ag change occurs that may be 
due to a reassortment of genes from a human virus strain with genes from a nonhuman virus; this 
is called antigenic shift. The only times that these shift events have been documented were in 
1957 and 1968, and marked increases in mortality and morbidity were noted (Langmuir and 
Schoenbaum, 1977). The most severe pandemic of influenza A virus that has occurred in modern 
times was the worldwide pandemic of 1918-1920 when over 20,000,000 deaths occurred 
(Collins, 1957). The virus that caused the 1918 pandemic has recently been partially 
characterized as having swine-like H1N1 sequences (Taubenberger et al., 1997), and serologic 
studies of individuals who were alive during that pandemic also strongly suggest that the virus 
had a swine-like HA Ag (Masurel and Marine, 1973).  
 
Importance of CD8+ CTL Cells 
Influenza virus-specific CTL have been shown in murine studies to limit influenza A 
virus replication and to protect against lethal influenza A virus challenge (Wells et al., 1981). 
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CTL have been found in the lungs of influenza A virus-infected mice (Yap and Ada, 1978), and 
recovery from influenza infection has correlated with clearance by CD8+ CTL (Mackenzie et al., 
1989). Virus-specific CTL clones that recognize epitopes on the nucleoprotein (NP), HA, 
nonstructural 1 (NS1) proteins, and influenza virus-stimulated immune splenocytes adoptively 
transferred into naive recipients reduced pulmonary virus titers after influenza virus challenge 
(Wells et al., 1981; Taylor and Askonas, 1986; Kuwano et al., 1988; Kuwano et al., 1990). The 
Ennis laboratory has shown that active immunization with an HA fusion protein that induced 
HA-specific CTL but not neutralizing Ab caused a reduction in peak lung virus titers after virus 
challenge and protection against a lethal challenge dose (Kuwano et al., 1989). Lack of CD8+ 
CTL delays viral clearance and increases mortality after infection with a virulent strain of 
influenza virus (Bender et tal., 1992). CD4+ virus-specific T cells may help compensate for the 
absence of CD8+ CTL because the virus can be cleared in CD8+ CTL-deficient mice; however, 
mice lacking both CD4+ and CD8+ CTL do not clear virus or survive (Eichelberger et al., 1991). 
Therefore, CTL seem to be important in both restricting influenza A virus replication and 
reducing disease severity.  
 
H5N1 
In 1997, an H5N1 influenza A virus was isolated from a 3-year-old boy in Hong Kong. 
This child did not survive the infection, and his was the first of six deaths due to H5N1 influenza 
A virus infections (Doepel, 1998). The isolated virus was found to be similar to avian H5N1 
viruses (Subbarao et al., 1998; Suarez et al., 1998).   The Ennis Laboratory speculated that most 
of the older children and adults living in Hong Kong and elsewhere in the world in 1997 would 
possess influenza A virus cross-reactive memory T cells, and that some of these clones would 
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recognize epitopes on the H5N1 avian-derived virus strains that caused human illness possibly 
providing partial protection from infection. There had been no other reports of the ability of 
human influenza A virus-specific CTL to recognize epitopes on nonhuman viruses. The Ennis 
lab developed and characterized a panel of human CD8+ and CD4+ CTL lines from several 
donors residing in a city in the U.S. (Jameson et al., 1998). These T cell lines were found to be 
either subtype specific or cross-reactive to the H1N1, H2N2, and H3N2 subtypes of human 
influenza A viruses (Jameson et al., 1998). They determined whether these human CD8+ and 
CD4+ CTL lines would recognize epitopes on autologous cells infected with influenza A virus 
strains of swine and avian species including the H5N1 virus strains recently isolated from 
patients in Hong Kong. In addition, they tested bulk culture responses of these donors to 
determine whether CTL cross-reactivity could be detected at the population level and quantitated 
the precursor frequency of CTL specific for epitopes on the H5N1 virus. 
These results demonstrated that adults living in an urban area of the U.S. possess 
influenza A cross-serotype reactive CD8+ and CD4+ CTL that recognize multiple epitopes on 
influenza A viruses of other species. Bulk culture cytotoxicity was demonstrated against avian 
and human influenza A viruses. Enzyme-linked immunospot assays detected precursor CTL 
specific for both human CTL epitopes and the corresponding A/HK/97 viral sequences. Ennis et 
al hypothesized that these cross-reactive CTL might provide partial protection to humans against 
novel influenza A virus strains introduced into humans from other species (Jameson et al., 1999). 
The results showed that adult humans with no known exposure to these nonhuman 
species possess high levels of memory CTL which are readily detected in bulk culture assays 
following stimulation with a human influenza A virus. The recognition of autologous cells 
infected with the recent Hong Kong H5N1 isolates or the older avian and swine-derived viruses 
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was convincing and was similar to the level of lysis of autologous cells infected with human 
influenza A viruses. These bulk culture results were in accord with the specific CTL lysis of 
target cells infected with the swine and avian-derived virus strains and the recent H5N1 isolates 
from Hong Kong by a panel of human CD8+ and CD4+ T cell lines, the majority of which are 
cross-reactive among the human H1, H2, and H3 subtypes.  
The cross-reactive recognition of epitopes by these CD8+ and CD4+ T cell clones fits well 
with available sequence data. Clones that recognized defined epitopes with no or minimal 
conserved mutations recognized target cells infected with the swine-derived Hsw1N1, the older 
avian virus strains H5N2 and H1N1, and the recent H5N1 isolates from Hong Kong similar to 
target cells infected with human H1N1 virus.  
 
Importance of Cross Reactive Memory T-Cells 
What are the effects of these preexisting human influenza A virus cross-reactive memory 
T cells when a new nonhuman influenza A virus is introduced into humans, as occurred in Hong 
Kong in 1997 (Webster et al., 1992) and might have occurred in 1918? There was relatively little 
influenza A virus activity noted in the two decades preceding the 1918 pandemic (Collins, 1957). 
An epidemic occurred in 1890 which appears to have been caused by a virus with an H3-like HA 
based on serological evidence of H3-specific Abs found before 1968 in the sera of individuals 
born before 1890 (Masurel and Marine, 1973). The reasons for the tremendous mortality during 
the 1918 pandemic are unknown. Young adults, especially the age group of 25-35 years, had 
very high mortality rates in 1918, which is unusual in influenza; deaths usually occur in the very 
young and in older individuals (Collins, 1957). Thus, a W-shaped curve in age-related mortality 
with the peak deaths between the ages of 25-35 was described instead of the usual U-shaped 
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curve with deaths peaking only in the very young and old (Collins, 19574). In addition to 
unusual virulence of the 1918 virus, memory immunologic responses, including cross-reactive 
influenza-specific T cell responses, may have been low or absent in some of the young adult 
cohort because there was relatively little influenza A activity noted during the two decades 
immediately before 1918 (Collins, 1957).  
The impact of influenza A cross-reactive memory CTL on the morbidity and mortality 
associated with influenza virus epidemics and the pandemics of 1918, 1957, and 1968 is 
unknown. In 1957, most adults presumably had cross-reactive CTL memory to epitopes on the 
H1N1 viruses which circulated widely before the "Asian" pandemic (H2N2) of 1957. Similarly, 
when the H3N2 "Hong Kong" virus emerged in 1968, adults and older children would be 
expected to have had cross-reactive memory CTL as a result of infection with the prior H2N2 
virus strains, and adults would also have been exposed to the earlier H1N1 strains. Although it is 
clear that cross-reactive memory T cells did not prevent infections and excess mortality in 1957 
and 1968, these memory T lymphocytes may have contributed a degree of partial protection by 
limiting the degree of viral replication, based on experimental studies of CTL in mouse models 
(Wells et al., 1981; Taylor and Askonas, 1986; Kuwano et al., 1988; Kuwano et al., 1990).  
Overall, those results suggest that adults living in urban areas have CD8+ and CD4+ 
memory CTL as a result of prior infections with human influenza A viruses, and these CTL are 
in large part cross-reactive to epitopes on influenza A virus strains derived from swine and avian 
species.   Most of the human CTL clones were able to recognize entirely conserved or mutated 
viruses. There is considerable conservation among the genes encoding the internal and 
nonstructural proteins of influenza A virus, which is consistent with those results. The presence 
of these memory T lymphocytes may play a role in helping to restrict virus replication, thereby 
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decreasing morbidity and mortality to a degree. These results support the hypothesis that cross-
reactive T cells will be activated in humans by infection with a novel influenza A virus derived 
from another species, and the activation of these memory CTL by infection may result in reduced 
replication of the new infecting virus. Stimulation of these crossreactive T cells by novel 
attempts at vaccination including plasmid DNA vaccines may induce protection against novel 
influenza viruses. 
Up to now no T cell epitope has been reported on the Influenza A HA in the human 
system, although several T cell epitopes were identified on the HA in mice (reviewed in 
McMichael 1994; Parker and Gould 1996). In The Ennis Laboratory’s studies (Jameson et al., 
1998; Jameson et al., 1999), they found an HA specific and HLA-B18-restricted CTL line, 10-
1G5, that originally recognized HA (H1N1), was crossreactive to H1, H2 and H5 subtypes. B18 
is not a common HLA allele, but that crossreactivity is very interesting for vaccine design. 
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PROJECT PURPOSE 
 
This MQP was designed to generate a recombinant vaccinia virus expressing the new H5 
subtype of the influenza virus HA gene as a part of a larger project to eventually define the CTL 
epitope on the avian HA protein that is recognized by human T cell clones during influenza 
infection. 
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MATERIALS AND METHODS 
 
 
Viruses, Antiserum and Cells  
Influenza virus A/Hong Kong/156/97 (H5N1) (A/HK/156/97) and ferret antiserum to this 
virus were kindly provided by N. J. Cox, World Health Organization Influenza Reference 
Laboratory, at the Centers for Disease Control and Prevention (Atlanta, GA) and propagated in 
embryonated chicken eggs.  Infected allantoic fluids were harvested 2 days after infection. Wild 
type vaccinia virus (ATCC #VR1354) was propagated in CV-1 cells. CV-1 cells (ATCC 
#CCL70) were maintained in complete MEM-10 (minimal essential medium containing 10% 
FCS, 0.03% glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin sulfate). HuTK-143B 
cells were maintained in complete MEM-10/BrdU (complete MEM with 25 µg/ml of 5-
bromodeoxyuridine). Both cells were kept in a humidified 37°C, 5% CO2 incubator. 
 
Plasmids  
The transfer vector, pMJ601, was a gift from Bernard Moss, National  
Institute of Allergy and Infectious Diseases (Bethesda, MD). The hemagglutinin (HA) gene of 
the A/HK/156/97 (H5N1) was amplified by the reverse transcriptase-polymerase chain reaction 
(RT-PCR) and cloned into the pCR2.1-TOPO vector (Invitrogen, Carlsbad, CA) in our 
laboratory.  
 
Generation of the Expression Recombinant Vaccinia Virus 
 
1. Generation of the transfer vector for homologous recombination  
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To eliminate a second ATG sequence which was located within the polylinker upstream 
of the first ATG of the HA cDNA (different reading frames) , the pCR2.1-HA was double-
digested with two restriction enzymes, EcoRV and NotI (New England Biolabs, Beverly, MA) 
and then treated with the Klenow fragment (New England Biolabs) under the presence of dNTPs 
to fill-in the 5’-overhang made by NotI digestion. The fragment was gel-purified using the 
Geneclean II Kit (Bio 101, Vista, CA) following the manufacturer’s recommendation. The 
purified fragment including the vector was self-ligated using the Fast-Link DNA Ligation Kit 
(Epicentre Tehnologies, Madison, WI) and used to transform the E. coli, INVαF’ (Invitrogen). 
Colonies were picked and cultured overnight in 5 ml of LB media containing 50 µg/ml of 
ampicillin. Plasmids were prepared using the QIAprep Spin Miniprep Kit (Qiagen, Valencia, 
CA) following the manufacturer’s recommendation, and screened by the NotI and EcoRV 
digestion. Absence of the ATG sequence before the first ATG of the HA gene was confirmed by 
nucleotide sequencing. Two unique restriction enzyme sites, XhoI and HindIII (Promega, 
Madison, WI) were used to cut out the cDNA, and the digested fragment was gel-purified. The 
transfer vector, pMJ601, was digested by the restriction enzymes, SalI and HindIII (Promega), 
and gel-purified. The ligation reactions between these two fragments were carried out using the 
Fast-Link DNA Ligation Kit (the XhoI-digested fragment is compatible to the SalI-digested 
fragment) and the ligation reaction mixture was used to transform the E. coli, INVαF’ 
(Invitrogen). The colonies were picked up and cultured over night in 5 ml of LB media 
containing 50 µg/ml of ampicillin (Sambrook et al., 1989). Plasmids were prepared using the 
QIAprep Spin Miniprep Kit and screened by the EcoRI digestion (Promega). The correct clone, 
pMJ-HA, was propagated in large scale (500 ml of LB media with ampicillin) and purified using 
the Wizard Plus Maxipreps DNA Purification System (Promega) following the manufacturer’s 
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recommendation. The quality and quantity of the purified plasmids were determined by 
measuring optical density at the wavelength of 260nm, and 280nm and 0.8% agarose gel 
electrophoresis.   
 
2. Generation of the recombinant vaccinia virus (Earl and Moss, 1993)  
1×106 CV-1 cells were seeded in a 25-cm2 flask the day before transfection. Two hours 
before transfection CV-1 cells were infected with 1 ml of diluted wild type vaccinia virus (0.05 
pfu/cell) in complete MEM-2.5 (2.5% of FCS). Cells were washed with PBS(-) and then 5 µg of 
pMJ-HA dissolved in 150 µl of TE, pH 8.0 mixed with 30 µl of SuperFect Transfection Reagent 
(Qiagen) was added to them. Cells were washed with PBS(-) after two hours incubation and 
cultured in complete MEM-10 for two days.  Transfected cells were harvested and resuspended 
in 0.5 ml of complete MEM-2.5. Cell lysate was prepared by the freeze-thaw cycling and stored 
at -70°C. Both thymidine kinase (TK) selection and β-galactosidase screenings were used. 
HuTK-143B cells were plated at 5×105/well in 6-well tissue culture dishes the day before 
infection. Transfected and infected cell lysates were trypsinized with the same amount of 0.25% 
trypsin, sonicated, and then three 10-fold serial dilutions (10-1 to 10-3) were made. Dilutions of 
10-2 and 10-3 were used to infect HuTK-143B cells. After two hours of incubation, inoculum was 
replaced by complete MEM-10 with BrdU for TK selection. After two days of incubation, basal 
eagle medium containing melted 1% low melting point agarose, 0.1 mg/ml neutral red, 25 µg/ml 
BrdU and 0.33 mg/ml X-gal was overlaid onto the cells for β-galactosidase screening. After 
over-night incubation blue plaques were picked up by sterile, cotton-plugged Pasteur pipets and 
added into 0.5 ml of MEM-2.5. Cell lysate was prepared by the freeze-thaw cycling and 
sonication, and 10-1 and 10-2 dilutions were used to infect HuTK-143B cells for plaque 
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purification. Plaque purification was repeated three times and then HuTK-143B cells in 12-well 
dish were infected with a half of cell lysate from the picked-up plaque. After two days cells were 
harvested, and a half of cell lysate was used to infect two 25-cm2 flasks of HuTK-143B cells, one 
of which was for RNA isolation and the other was for large scale culture. After two days of 
incubation, cells were harvested, and cell lysate or RNA was prepared. One half of the cell lysate 
was used to infect a 175-cm2 flask of CV-1 cells, and cells were harvested after three days of 
incubation, resuspended in 2 ml of complete MEM-2.5, freeze-thawed, sonicated and stored at -
70°C. The virus titer was measured by infecting CV-1 monolayers seeded in a 6-well dish with 
serial dilutions of the virus stock.    
 
Detection of the HA Gene Product 
1. RT-PCR  
Total cellular RNA was isolated from infected HuTK-143B cells with the recombinant 
vaccinia virus using the Ultraspec RNA isolation system (Biotecx Laboratories, Houston, TX) 
following the manufacturer’s protocol.  Positive control, influenza viral RNA was isolated from 
infected allantoic fluid using the Ultraspec RNA isolation system. RNAs isolated from infected 
HuTK-143B cells were treated with DNaseI to eliminate the contaminated vaccinia virus 
genomic DNA and purified again using the Ultraspec RNA isolation system. To synthesize the 
cDNA, 2 µg of total RNA was added to the reaction mixture containing 50 mM Tris-HCl (pH 8.3 
at 25°C), 50 mM KCl, 10 mM MgCl2, 0.5 mM spermidine, 5 mM DTT, 0.5 mM dNTPs, 100 
units of RNAguard (Pharmacia Biotech, Piscataway, NJ), 0.1 A260 units of pd(N)6 Random 
Hexamer (Pharmacia Biotech) and 30 units of AMV reverse transcriptase (Promega) in 100 µl. 
The RT reaction was performed at 42°C for 60 min followed by heat inactivation at 95°C for 10 
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min. The HA gene was amplified by a HA specific primer set: upstream primer (HA167192): 5’-
GACATACTGGAAAGGACACACAACGG-3’; downstream primer (HA942966): 5’-
AGGGGGTGTATGTTGTGGAATGGCA-3’. This primer set produces an 800 bp fragment. The 
PCR was performed using GeneAmp XL PCR Kit (PE Applied Biosystems, Foster City, CA). 
One µl of cDNA was added to a PCR reaction mixture containing 1× XL buffer II, 0.2 mM 
dNTPs, 0.8 mM Mg(OAc)2, 0.25 pmol/µl of each primer and 2 units of rTth DNA Polymerase, 
XL in 100 µl. PCR was performed in a DNA Thermal Cycler 480 (PE Applied Biosystems) at 
94°C for 60 seconds, followed by 30 cycles of 94°C for 30 sec and 65°C for 5 min, and finally 1 
cycle of 72°C for 10 min. 10 µl of PCR product was subjected to 1.4% agarose gel 
electrophoresis and the gel was stained with ethidium bromide.    
 
2. Immunoprecipitation  
75-cm2 flask of CV-1 cells were infected with approximately 106 pfu of recombinant 
vaccinia virus or wild type vaccinia virus. After two hours of incubation, CV-1 monolayers were 
washed with long-term labeling media (9 volumes of methionine-free RPMI medium was mixed 
with 1 volume of complete serum-free RPMI medium, and fetal calf serum was added to 10%) 
and cultured over-night. Long-term labeling media contained 0.1 mCi/ml of [35S] methionine 
(Bonifacino, 1991). Labeled cells were washed with ice-cold PBS twice, then lysis buffer/wash 
buffer 1 from the Immunoprecipitation Kit (Protein A) (Boehringer Mannheim) was added onto 
them. Cells were scraped and homogenized. The supernatant (approximately 1 ml) was separated 
by centrifugation at 12000 × g, 10 min, 4°C and transferred to a new tube. 5 µl of ferret anti-
serum raised against A/HK/156/97 (H5N1) was added to the supernatant and the mixture was 
incubated at 4°C for an hour. 50 µl of protein A-agarose suspension was added to the mixture. 
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After three hours incubation complexes were collected by centrifugation at 12000 × g for 1 min, 
and the pellet was resuspended in lysis buffer/wash buffer and incubated 20 min at 4°C for 
washing. The complexes were collected again by centrifugation at 12000 × g,  for 1 min, and 
then this washing step was repeated. Then the pellet was washed with wash buffer 2 twice in the 
same way and with wash buffer 3 once. After washing 50 µl of 2×gel-loading buffer (100 mM 
Tris-HCl (pH 6.8), 200 mM dithiothreitol, 4% SDS, 0.2% bromophenol blue and 20% glycerol) 
was added to the pellet and 30 µl of the mixture was subjected to 10% SDS-polyacrylaminde gel 
electrophoresis. After electrophoresis the gel was fixed and analyzed by Bio-Rad Multi-Analyst 
Version 1.0.2.   
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RESULTS 
 
Generation of the transfer vector for homologous recombination 
Influenza virus A/Hong Kong/156/97 (H5N1) (A/HK/156/97) was propagated in 
embryonated chicken eggs, and the viral hemagglutinin (HA) gene was amplified by RT-PCR 
(data not shown) and cloned into plasmid pCR2.1-TOPO to generate plasmid pCR2.1-HA 
(Figure 1).   
 
 
 
 
 
 
 
 
 
 CTCGAGCGGCCGCCAGTGTGATGGATATCTGCAGAATTCGCCCTTCAAAATG 
    XhoI       NotI                               EcoRV             EcoRI 
 
 B 
 
 CTCGAGCGGCCATCTGCAGAATTCGCCCTTCAAAATG 
    XhoI                                  EcoRI 
 
Figure 1.  Map of Plasmid pCR2.1-HA.  This plasmid contains the H5N1 HA gene 
amplified by RT-PCR and cloned into vector pCR2.1-TOPO (Panel A).  The letters 
immediately beneath the map denote the 5’ end of the HA cDNA (CAAAATG in italics) 
downstream from the EcoRI site within the polylinker.   Two ATG sites are bolded, the 
first one occurs in the polylinker, and the second one within the HA gene.  After 
NotI/EcoRV restriction enzyme digestion, fill-in reaction and self-ligation, the extra 
ATG within the polylinker was eliminated (B) to prevent false translational initiation.  
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Sequence analysis verified that pCR2.1-HA encodes the same HA amino acid sequence 
as GenBank Accession AF036356, but differs from Accession AF028709.  To eliminate false 
translation from a second ATG sequence located within the polylinker upstream from the HA 
ATG, plasmid pCR2.1-HA was double-digested with EcoRV and NotI (Figure 1A) (which flank 
the ATG to be removed), made blunt by Klenow fill-in, then self-ligated.  Self-ligated plasmid 
was transformed into E. coli INVαF’, and ampr plasmids were screened by NotI and EcoRV 
digestion. Absence of the polylinker ATG sequence was confirmed by nucleotide sequencing. 
 The HA gene (minus the polylinker ATG) was excised from pCR2.1-HA by digestion 
with XhoI and HindIII (Figure 1A).  This HA fragment was ligated into vaccinia transfer vector 
pMJ601 (Figure 2) pre-digested with SalI and HindIII (the XhoI-digested fragment is compatible 
with the SalI-digested fragment).  The ligated plasmid was transformed into E. coli, and ampr 
colonies were screened by EcoRI digestion.  The correct clone, pMJ-HA, was propagated large 
scale, and was used to make recombinant vaccinia virus expressing the HA.. 
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Figure 2.  Map of Vaccinia Transfer Vector pMJ601.  The synthetic late 
promoter, multiple cloning sites, P7.5 promoter and lacZ gene are flanked by the 
right (TKR) and the left (TKL) half of the thymidine kinase gene for homologous 
recombination. 
 
Generation of Recombinant Vaccinia Virus Expressing HA 
Wild type vaccinia virus was propagated in CV-1 cells, then transfected with plasmid 
pMJ-HA.   Three independent blue plaques were picked and purified by three rounds of plaque 
purification.  These potential positive virus clones were used to infect HuTK-negative cells, and 
total cellular RNA was screened by RT-PCR for expression of HA mRNA (Figure 3).  
 
 
 
 
 
 
 
 
 
Figure 3.  RT-PCR Screen of H5N1 HA mRNA Expression .  Total cellular 
RNA isolated from HuTK-143B cells infected with the recombinant vaccinia 
virus (rVV) or influenza viral RNA (Positive Control Flu) isolated from infected 
allantoic fluid were reverse transcribed with (+) or without (-) AMV reverse 
transcriptase.  The strong band at around 800 bp denotes the presence of HA 
mRNA. 
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Two of  three clones examined were positive for the HA gene expression, and one clone 
was chosen for large scale propagation.   The virus titer of this preparation was 2.2×108 pfu/ml 
(Figure 4) and comparable to wild type or other recombinant vaccinia viruses prepared in our 
laboratory. 
     
 
 
 
 
 
 
 
 
 
 
Figure 4. Titration of the Recombinant H5N1 Vaccinia Virus. Viral plaques 
are seen as round white or transparent spots after crystal violet staining. 
Duplicate wells of each dilution are shown. 
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Detection of HA Protein Expression 
Immunoprecipitation by antiserum against A/HK/156/97 (H5N1) was performed to detect 
levels of HA protein from the recombinant virus (figure 5). The expected molecular weights of 
proteins HA, HA1 and HA2 were approximately 77, 50 and 27 kDa, respectively (Lamb and 
Chopin, 1983).   
 
Figure 5. Detection of H5N1 HA Protein by Immunoprecipitation. Cell 
lysates from uninfected CV-1 cells (CV-1), CV-1 cells infected with wild type 
vaccinia virus (wtVV) or recombinant vaccinia virus were immunoprecipitated 
by antiserum against A/HK/156/97 (H5N1). Top arrow shows 77 kDa HA, and 
bottom arrow shows 27 kDa HA2, respectively. 
 
The SDS-PAGE analysis of uninfected CV-1 cells (left lane) showed some nonspecific bands, 
but the cell lysate prepared from CV-1 cells infected with the recombinant vaccinia virus (lane 3) 
had a strong band at 77 kDa whose molecular weight is identical to HA (figure 5, top arrow). 
The infected cells also showed a faint band about 27 kDa in size (figure 5, lower arrow) which 
likely corresponds to the HA2 subunit.  It was not clear if there was a 50 kDa band because of 
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the presence of a nonspecific band at 50 kDa, although its intensity increased markedly in 
vaccinia infected cells as expected for HA1. These results showed that the H5N1 HA gene was 
indeed expressed, and that a small portion of the HA protein was correctly cleaved into HA1 and 
HA2.   
 24
 
DISCUSSION 
 
A recombinant vaccinia virus expressing the HA gene of the new influenza virus H5 
subtype was generated, and the expression of the HA gene product was confirmed at both 
transcriptional and translational levels.  This recombinant vaccinia virus will be used in the 
future to confirm that the avian HA protein is recognized by a human T cell clone, 10-1G5, 
which is the first example of a human CTL specific to the HA.  Truncated forms of this 
recombinant vaccinia virus HA and/or synthetic HA peptides could then be used to precisely 
identify the T cell epitope on the HA protein. This recombinant vaccinia virus will also be useful 
to identify and isolate T cell lines specific for H5 HA to determine whether T cell lines exist that 
are crossreactive to the H5 subtype and to other influenza A virus HA proteins using PBMC 
obtained from patients and/or healthy volunteers. 
The generation and characterization of this recombinant vaccinia / influenza H5 HA virus 
will be a useful reagent to better identify and define the roles of influenza A virus HA-specific T 
cells.   
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